News
A team of researchers led by Prof. Xiao Jun from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese ...
Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.
Latus Bio Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced upcoming oral and ...
Discover a study where researchers administered appetite-related hormones leptin and ghrelin directly into the brain.
Study Finds Synergistic Convergence of Global Warming, Pesticide Toxicity, and Antibiotic Resistance
Pesticides by themselves are a grave threat to global health. As is global warming. As is antibiotic resistance. Each of ...
In recent years, the development of sophisticated methodologies based on second- and third-generation sequencing has enabled the RNA community to explore ...
Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...
Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...
Ghost Drops, a prominent player in Canada's cannabis industry, has formally filed a legal claim against Health Canada. This action comes in response to mounting regulatory pressure regarding the brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results